drugset / Trial / NCT04700449
A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the efficacy and safety of CBP-307 in subjects with moderate to severe ulcerative colitis (UC).
Timeline
- Start
- 2019-02-27
- Primary completion
- 2022-02-23
- Completion
- 2022-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBP-307 | Unknown | 0.1 mg | Oral |
| Subject | CBP-307 | Unknown | 0.2 mg | Oral |